106 related articles for article (PubMed ID: 25018052)
1. 6-iodolactone, key mediator of antitumoral properties of iodine.
Nava-Villalba M; Aceves C
Prostaglandins Other Lipid Mediat; 2014 Aug; 112():27-33. PubMed ID: 25018052
[TBL] [Abstract][Full Text] [Related]
2. A complex between 6-iodolactone and the peroxisome proliferator-activated receptor type gamma may mediate the antineoplastic effect of iodine in mammary cancer.
Nuñez-Anita RE; Arroyo-Helguera O; Cajero-Juárez M; López-Bojorquez L; Aceves C
Prostaglandins Other Lipid Mediat; 2009 Jun; 89(1-2):34-42. PubMed ID: 19443248
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR).
Aceves C; García-Solís P; Arroyo-Helguera O; Vega-Riveroll L; Delgado G; Anguiano B
Mol Cancer; 2009 Jun; 8():33. PubMed ID: 19500378
[TBL] [Abstract][Full Text] [Related]
4. Uptake and antitumoral effects of iodine and 6-iodolactone in differentiated and undifferentiated human prostate cancer cell lines.
Aranda N; Sosa S; Delgado G; Aceves C; Anguiano B
Prostate; 2013 Jan; 73(1):31-41. PubMed ID: 22576883
[TBL] [Abstract][Full Text] [Related]
5. 6 Iodo-δ-lactone: a derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells.
Thomasz L; Oglio R; Rossich L; Villamar S; Perona M; Salvarredi L; Dagrosa A; Pisarev MA; Juvenal GJ
Prostaglandins Leukot Essent Fatty Acids; 2013 Apr; 88(4):273-80. PubMed ID: 23375358
[TBL] [Abstract][Full Text] [Related]
6. Evidence that iodolactones are the mediators of growth inhibition by iodine on the thyroid.
Gärtner R; Dugrillon A; Bechtner G
Acta Med Austriaca; 1996; 23(1-2):47-51. PubMed ID: 8767514
[TBL] [Abstract][Full Text] [Related]
7. The role of iodine and delta-iodolactone in growth and apoptosis of malignant thyroid epithelial cells and breast cancer cells.
Gärtner R; Rank P; Ander B
Hormones (Athens); 2010; 9(1):60-6. PubMed ID: 20363723
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor gamma is crucial for antitumoral effects of 6-iodolactone.
Nava-Villalba M; Nuñez-Anita RE; Bontempo A; Aceves C
Mol Cancer; 2015 Sep; 14():168. PubMed ID: 26376791
[TBL] [Abstract][Full Text] [Related]
9. Thyroid autoregulation. Inhibitory effects of iodinated derivatives of arachidonic acid on iodine metabolism.
Chazenbalk GD; Valsecchi RM; Krawiec L; Burton G; Juvenal GJ; Monteagudo E; Chester HA; Pisarev MA
Prostaglandins; 1988 Aug; 36(2):163-72. PubMed ID: 3141976
[TBL] [Abstract][Full Text] [Related]
10. Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effects.
Arroyo-Helguera O; Rojas E; Delgado G; Aceves C
Endocr Relat Cancer; 2008 Dec; 15(4):1003-11. PubMed ID: 18827038
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic effect of iodine and iodide in dimethylbenz[a]anthracene-induced mammary tumors: association between lactoperoxidase and estrogen-adduct production.
Soriano O; Delgado G; Anguiano B; Petrosyan P; Molina-Servín ED; Gonsebatt ME; Aceves C
Endocr Relat Cancer; 2011 Aug; 18(4):529-39. PubMed ID: 21690268
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative/cytotoxic activity of molecular iodine and iodolactones in various human carcinoma cell lines. No interfering with EGF-signaling, but evidence for apoptosis.
Rösner H; Torremante P; Möller W; Gärtner R
Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):410-9. PubMed ID: 19802778
[TBL] [Abstract][Full Text] [Related]
13. Thyroid autoregulation. Inhibition of goiter growth and of cyclic AMP formation in rat thyroid by iodinated derivatives of arachidonic acid.
Pisarev MA; Chazenbalk GD; Valsecchi RM; Burton G; Krawiec L; Monteagudo E; Juvenal GJ; Boado RJ; Chester HA
J Endocrinol Invest; 1988 Oct; 11(9):669-74. PubMed ID: 2851622
[TBL] [Abstract][Full Text] [Related]
14. Molecular iodine exerts antineoplastic effects by diminishing proliferation and invasive potential and activating the immune response in mammary cancer xenografts.
Mendieta I; Nuñez-Anita RE; Nava-Villalba M; Zambrano-Estrada X; Delgado-González E; Anguiano B; Aceves C
BMC Cancer; 2019 Mar; 19(1):261. PubMed ID: 30902074
[TBL] [Abstract][Full Text] [Related]
15. Iodolactones and iodoaldehydes--mediators of iodine in thyroid autoregulation.
Dugrillon A
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():41-5. PubMed ID: 8981000
[TBL] [Abstract][Full Text] [Related]
16. Evidence that thyroid growth autoregulation is mediated by an iodolactone.
Gärtner R; Dugrillon A; Bechtner G
Acta Med Austriaca; 1990; 17 Suppl 1():24-6. PubMed ID: 2167602
[TBL] [Abstract][Full Text] [Related]
17. Regulation of NADPH oxidase NOX4 by delta iodolactone (IL-δ) in thyroid cancer cells.
Thomasz L; Oglio R; Salvarredi L; Perona M; Rossich L; Copelli S; Pisarev M; Juvenal G
Mol Cell Endocrinol; 2018 Jul; 470():115-126. PubMed ID: 28993239
[TBL] [Abstract][Full Text] [Related]
18. Molecular Iodine Has Extrathyroidal Effects as an Antioxidant, Differentiator, and Immunomodulator.
Aceves C; Mendieta I; Anguiano B; Delgado-González E
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513754
[TBL] [Abstract][Full Text] [Related]
19. The extrathyronine actions of iodine as antioxidant, apoptotic, and differentiation factor in various tissues.
Aceves C; Anguiano B; Delgado G
Thyroid; 2013 Aug; 23(8):938-46. PubMed ID: 23607319
[TBL] [Abstract][Full Text] [Related]
20. Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line.
Arroyo-Helguera O; Anguiano B; Delgado G; Aceves C
Endocr Relat Cancer; 2006 Dec; 13(4):1147-58. PubMed ID: 17158760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
